Solid oral dosage form containing an enhancer
US7704977B2 · kind B2 · utility
104Cited by
32References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 9, 2007 |
| Grant date | Apr 27, 2010 |
| Priority date | — |
| Expiry date | Jul 30, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a pharmaceutical composition and oral dosage forms comprising a bisphosphonate in combination with an enhancer to enhance intestinal delivery of the bisphosphonate to the underlying circulation. Preferably, the enhancer is a medium chain fatty acid or a medium chain fatty acid derivative having a carbon chain length of from 6 to 20 carbon atoms, and the solid oral dosage form is a controlled release dosage form such as a delayed release dosage form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.